EOSE
Eos Energy Enterprises, Inc.
There isn't enough reported data to score EOSE yet.
TBI
TrueBlue, Inc.
TBI lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve.
EOSE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
EOSE's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
TBI Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Under pressure | |
| Weak |
TBI's revenue is currently healthy, but its profitability, cash flow and balance sheet are under pressure.
EOSE PE Valuation
EOSE has no meaningful PE right now: it lost money over the past year.
TBI PE Valuation
TBI has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 18x next year's earnings.
EOSE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect EOSE's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
TBI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect TBI to return to profit, with revenue growing.
EOSE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$2.69 | +$0.85 |
| Q2 2023 | -$3.76 | -$1.00 |
| Q1 2023 | -$3.65 | -$0.86 |
| Q4 2022 | -$3.68 | -$1.32 |
| Q3 2022 | -$3.54 | +$5.19 |
EOSE has the stronger earnings trend. Trailing diluted EPS is down 224% for EOSE versus TBI down 261%.
TBI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.69 | — |
| Q3 2026 | -$1.55 | -$0.59 |
| Q2 2026 | -$1.89 | -$0.73 |
| Q1 2026 | -$1.79 | +$2.81 |
| Q4 2025 | -$1.61 | +$2.56 |
| Q3 2025 | -$0.96 | +$2.88 |
| Q2 2025 | -$1.16 | +$2.42 |
| Q1 2025 | -$4.60 | -$4.23 |
| Q4 2024 | -$4.17 | -$3.72 |
TBI is still losing money, but far less than before: $1.55 per share over the past year, against $4.60 at its worst in early 2025.
EOSE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $82.7M | +171% |
| Q2 2026 | $68.8M | +351% |
| Q1 2026 | $57M | +445% |
| Q4 2025 | $58M | +700% |
| Q3 2025 | $30.5M | +3473% |
| Q2 2025 | $15.2M | +1597% |
| Q1 2025 | $10.5M | +58% |
| Q4 2024 | $7.3M | +9.7% |
EOSE has the edge over TBI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -96% | +105 points |
| Q2 2026 | -122% | +297 points |
| Q1 2026 | -139% | +367 points |
| Q4 2025 | -140% | +573 points |
| Q3 2025 | -201% | +6044 points |
| Q2 2025 | -419% | +2815 points |
| Q1 2025 | -506% | +117 points |
| Q4 2024 | -713% | -74 points |
EOSE's operating margin was −96% last quarter, up 105 points from the same quarter a year ago, near the top of its range since 2019.
TBI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $520.7M | +21% |
| Q2 2026 | $443M | +12% |
| Q1 2026 | $398.6M | +7.6% |
| Q4 2025 | $418.2M | +8.3% |
| Q3 2025 | $431.3M | +13% |
| Q2 2025 | $396.3M | 0% |
| Q1 2025 | $370.3M | -8.1% |
| Q4 2024 | $386M | -22% |
TBI's revenue is recovering but still below its 2021 peak: $521M last quarter, up 21% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.3% | +2.3 points |
| Q2 2026 | -0.3% | +0.5 points |
| Q1 2026 | -4.5% | -0.7 points |
| Q4 2025 | -7% | -4.3 points |
| Q3 2025 | 0% | +1.8 points |
| Q2 2025 | -0.7% | +14 points |
| Q1 2025 | -3.8% | 0 points |
| Q4 2024 | -2.7% | -1 points |
TBI has the edge over EOSE on profitability, with a higher operating margin.
EOSE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$105.1M | -$22.4M |
| Q2 2026 | -$107.4M | -$34.3M |
| Q1 2026 | -$154.8M | -$121M |
| Q4 2025 | -$75.2M | -$19.5M |
| Q3 2025 | -$82.7M | -$28.5M |
| Q2 2025 | -$73.2M | -$40.6M |
| Q1 2025 | -$33.8M | +$10.7M |
| Q4 2024 | -$55.8M | -$10.2M |
EOSE has burned cash in almost every quarter: −$443M over the past year, against −$246M the year before.
TBI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$28.3M | -$4.9M |
| Q2 2026 | -$24M | -$7.9M |
| Q1 2026 | -$12.6M | +$14.2M |
| Q4 2025 | -$7.5M | -978% |
| Q3 2025 | -$23.4M | -$10.7M |
| Q2 2025 | -$16.1M | -$8.3M |
| Q1 2025 | -$26.8M | -$5.2M |
| Q4 2024 | $854K | -88% |
TBI has burned cash in seven of the last eight quarters: −$72M over the past year, against −$65M the year before.
EOSE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +63% | +213M shares |
| 1 year | +161% | +341M shares |
| 3 years | +888% | +497M shares |
EOSE has 553M diluted shares, up 161% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
TBI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +7.3% | +2.2M shares |
| 1 year | +9.2% | +2.7M shares |
| 3 years | +5.5% | +1.7M shares |
| 5 years | -8% | -2.8M shares |
| Available history | -17% | -6.5M shares |
TBI has the edge over EOSE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $8,000 |
| Q3 2024 | $4.3M |
| Q2 2024 | $6.9M |
| Q1 2024 | $10.1M |
EOSE Net Leverage
EOSE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
TBI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | 929.0x | High |
| Q4 2023 | -31.4x | Net Cash |
| Q3 2023 | -2.7x | Net Cash |
| Q2 2023 | -1.1x | Net Cash |
| Q1 2023 | -0.6x | Net Cash |
| Q4 2022 | -0.7x | Net Cash |
| Q3 2022 | -0.4x | Net Cash |
| Q2 2022 | -0.3x | Net Cash |
TBI's net debt is more than 20 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.
EOSE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.5 | Neutral |
| Stochastic | 7.4 | Oversold |
EOSE's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
TBI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 70.8 | Overbought |
| Stochastic | 74.6 | Neutral |
TBI's weekly RSI is 71 (overbought) and its Stochastic is 75 (neutral).
EOSE PE vs Industrials Sector
EOSE has no meaningful PE right now: it lost money over the past year.
TBI PE vs Industrials Sector
| Metric | TBI | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
TBI has no meaningful PE right now: it lost money over the past year.
EOSE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.24 | 19% below |
| 20 week MA | $3.28 | 45% below |
| 50 week MA | $7.01 | 74% below |
| 100 week MA | $7.10 | 75% below |
| 200 week MA | $4.53 | 60% below |
EOSE is in a downtrend: it's below all five of its weekly moving averages, and 60% below its 200-week average.
TBI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.92 | 24% above |
| 20 week MA | $9.34 | 32% above |
| 50 week MA | $6.73 | 84% above |
| 100 week MA | $6.42 | 92% above |
| 200 week MA | $9.78 | 26% above |
TBI has the edge over EOSE on trend strength, trading above more of its moving averages.
EOSE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.72 | $19.2 | +98% |
| 2021 | $19.2 | $8.57 | -55% |
| 2022 | $8.57 | $1.08 | -87% |
| 2023 | $1.08 | $1.09 | +0.9% |
| 2024 | $1.09 | $5.17 | +374% |
| 2025 | $5.17 | $11.9 | +129% |
| 2026 YTD | $11.9 | $1.81 | -85% |
EOSE's yearly returns have swung widely, from +374% in 2024 to −87% in 2022. It's down 85% so far in 2026.
TBI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $23.6 | $19.2 | -19% |
| 2021 | $19.2 | $27.7 | +44% |
| 2022 | $27.7 | $19.2 | -30% |
| 2023 | $19.2 | $15.3 | -20% |
| 2024 | $15.3 | $7.87 | -49% |
| 2025 | $7.87 | $4.65 | -41% |
| 2026 YTD | $4.65 | $12.4 | +166% |
TBI has the edge over EOSE on returns for 2026, with the stronger performance.